Characterization of a surrogate murine antibody to model anti-human CD3 therapies

Fc-modified anti-human CD3ε monoclonal antibodies (mAbs) are in clinical development for the treatment of autoimmune diseases. These next generation mAbs have completed clinical trials in patients with type-1 diabetes and inflammatory bowel disease demonstrating a narrow therapeutic window. Lowered...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Dépis, Fabien, Hatterer, Eric, Ballet, Romain, Daubeuf, Bruno, Cons, Laura, Glatt, Sophie, Reith, Walter, Kosco-Vilbois, Marie, Dean, Yann
Format: Artigo
Jezik:Inglês
Izdano: Landes Bioscience 2013
Teme:
Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3906309/
https://ncbi.nlm.nih.gov/pubmed/23751612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.24736
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki